The role of bone marrow biopsy in Hodgkin lymphoma staging: 'To be, or not to be, that is the question'?

The article comments on a study on routine bone marrow biopsy for Hodgkin lymphoma (HL) by S. Richardson and colleagues published in this journal. The study included 392 patients with HL, including 190 patients with advanced stage disease and 202 patients with early stage disease. The author observes that the result revealed that BMB should not be performed routinely in HL patients undergoing positron emission tomography staging.